valsartan has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelaziz, RR; Abo-Khookh, AM; Ghoneim, HA; Nader, MA; Shawky, NM | 1 |
1 other study(ies) available for valsartan and Metabolic Diseases
| Article | Year |
|---|---|
The dual inhibitor Sacubitril-valsartan ameliorate high-fat high-fructose-induced metabolic disorders in rats superiorly compared to valsartan only.
Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cattle; Drug Combinations; Heart Failure; Insulin; Metabolic Diseases; Rats; Tetrazoles; Valsartan | 2023 |